The study aimed to validate the Cleveland Clinic malignancy probability prediction model for incidental pulmonary nodules using data from two medical centers.
Researchers collected data from 296 patients over nearly a year, comparing predictions of malignant nodules against actual outcomes at various time points.
Results showed that the Cleveland Clinic model performed consistently well in predicting malignancy, suggesting it can effectively aid in clinical decision-making for patients with high-risk pulmonary nodules.